Creatine and Creatinine Metabolism - Physiological Reviews

1192 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80
GABA/noradrenaline transporter family. J Mol Biol 241: 317–324,
1994.
319. GUIMBAL C AND KILIMANN MW. A Na � -dependent creatine
transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning
and functional expression. J Biol Chem 268: 8418–8421, 1993.
320. GUO D, SCHUT HAJ, DAVIS CD, SNYDERWINE EG, BAILEY GS,
AND DASHWOOD RH. Protection by chlorophyllin and indole-3carbinol
against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
(PhIP)-induced DNA adducts and colonic aberrant crypts in the
F344 rat. Carcinogenesis 16: 2931–2937, 1995.
321. GURRERI G, GHIGGERI G, SALVIDIO G, GARIBOTTO G,
ROBAUDO C, AND DEFERRARI G. Effects of hemodialysis on
guanidinopropionic acid metabolism. Nephron 42: 295–297, 1986.
322. GUTHMILLER P, VAN PILSUM JF, BOEN JR, AND MCGUIRE DM.
Cloning and sequencing of rat kidney L-arginine:glycine amidinotransferase.
Studies on the mechanism of regulation by growth
hormone and creatine. J Biol Chem 269: 17556–17560, 1994.
323. HAGENFELDT L, VON DÖBELN U, SOLDERS G, AND KAIJSER L.
Creatine treatment in MELAS. Muscle Nerve 17: 1236–1237, 1994.
324. HAGHIGHI AZ AND MAPLES KR. On the mechanism of the inhibition
of glutamine synthetase and creatine phosphokinase by
methionine sulfoxide. J Neurosci Res 43: 107–111, 1996.
325. HALL N AND DELUCA M. The effect of inorganic phosphate on
creatine kinase in respiring rat heart mitochondria. Arch Biochem
Biophys 229: 477–482, 1984.
326. HAMAHATA A, TAKATA Y, GOMI T, AND FUJIOKA M. Probing the
S-adenosylmethionine-binding site of rat guanidinoacetate methyltransferase.
Effect of site-directed mutagenesis of residues that
are conserved across mammalian non-nucleic acid methyltransferases.
Biochem J 317: 141–145, 1996.
327. HAMBURG RJ, FRIEDMAN DL, AND PERRYMAN MB. Metabolic
and diagnostic significance of creatine kinase isoenzymes. Trends
Cardiovasc Med 1: 195–200, 1991.
328. HAMILTON SM AND TEEL RW. Effects of isothiocyanates on
cytochrome P-450 1A1 and 1A2 activity and on the mutagenicity of
heterocyclic amines. Anticancer Res 16: 3597–3602, 1996.
329. HAMMAN BL, BITTL JA, JACOBUS WE, ALLEN PD, SPENCER
RS, TIAN R, AND INGWALL JS. Inhibition of the creatine kinase
reaction decreases the contractile reserve of isolated rat hearts.
Am J Physiol Heart Circ Physiol 269: H1030–H1036, 1995.
330. HAMMONS GJ, MILTON D, STEPPS K, GUENGERICH FP,
TUKEY RH, AND KADLUBAR FF. Metabolism of carcinogenic
heterocyclic and aromatic amines by recombinant human cytochrome
P450 enzymes. Carcinogenesis 18: 851–854, 1997.
331. HANDLOGTEN ME AND KILBERG MS. Induction and decay of
amino acid transport in the liver. J Biol Chem 259: 3519–3525,
1984.
332. HAPPE HK AND MURRIN LC. In situ hybridization analysis of
CHOT1, a creatine transporter, in the rat central nervous system.
J Comp Neurol 351: 94–103, 1995.
333. HARMOINEN APT. Bilirubin and metamizol do not interfere with
the Randox enzymatic creatinine test. An evaluation of a new
enzymatic creatinine determination method. Eur J Clin Chem
Clin Biochem 34: 975–976, 1996.
334. HARMS C. Anaerober Kreatin-Stoffwechsel in Tissierella creatinophila:
Anreicherung und Charakterisierung beteiligter Proteine,
besonders von verschiedenen Komponenten der Sarkosin-
Reduktase. Göttingen, Germany: Georg-August-Universität, 1995.
335. HARMS C, SCHLEICHER A, COLLINS MD, AND ANDREESEN JR.
Tissierella creatinophila sp. nov, a Gram-positive, anaerobic,
non-spore-forming, creatinine-fermenting organism. Int J Syst
Bacteriol 48: 983–993, 1998.
336. HARRIDGE SDR, BALSOM PD, AND SÖDERLUND K. Creatine
supplementation and electrically evoked human muscle fatigue.
Clin Sci 87 Suppl: 124–125, 1994.
337. HARRIS RC AND HULTMAN E. Muscle phosphagen status studied
by needle biopsy. In: Energy Metabolism: Tissue Determinants
and Cellular Corollaries, edited by J. M. Kinney and H. N. Tucker.
New York: Raven, 1992, p. 367–379.
338. HARRIS RC, SÖDERLUND K, AND HULTMAN E. Elevation of
creatine in resting and exercised muscle of normal subjects by
creatine supplementation. Clin Sci 83: 367–374, 1992.
339. HARRIS RC, VIRU M, GREENHAFF PL, AND HULTMAN E. The
effect of oral creatine supplementation on running performance
during maximal short term exercise. J Physiol (Lond) 467: 74P,
1993.
340. HARTMAN PE. Putative mutagens and carcinogens in foods. I.
Nitrate/nitrite ingestion and gastric cancer mortality. Environ
Mutagen 5: 111–121, 1983.
341. HASAN K, HEESEN B-J, CORBETT JA, MCDANIEL ML, CHANG
K, ALLISON W, WOLFFENBUTTEL BHR, WILLIAMSON JR, AND
TILTON RG. Inhibition of nitric oxide formation by guanidines.
Eur J Pharmacol 249: 101–106, 1993.
342. HASEGAWA R, KATO T, HIROSE M, TAKAHASHI S, SHIRAI T,
AND ITO N. Enhancement of hepatocarcinogenesis by combined
administration of food-derived heterocyclic amines at low doses
in the rat. Food Chem Toxicol 34: 1097–1101, 1996.
343. HASEGAWA R, MIYATA E, FUTAKUCHI M, HAGIWARA A, NA-
GAO M, SUGIMURA T, AND ITO N. Synergistic enhancement of
hepatic foci development by combined treatment of rats with 10
heterocyclic amines at low doses. Carcinogenesis 15: 1037–1041,
1994.
344. HASEGAWA R, YOSHIMURA I, IMAIDA K, ITO N, AND SHIRAI T.
Analysis of synergism in hepatocarcinogenesis based on preneoplastic
foci induction by 10 heterocyclic amines in the rat. Jpn J
Cancer Res 87: 1125–1133, 1996.
345. HASHIMOTO H, YANAGAWA Y, SAWADA M, ITOH S, DEGUCHI
T, AND KAMATAKI T. Simultaneous expression of human CYP3A7
and N-acetyltransferase in Chinese hamster CHL cells results in
high cytotoxicity for carcinogenic heterocyclic amines. Arch Biochem
Biophys 320: 323–329, 1995.
346. HASSINEN IE, VUORINEN KH, YLITALO K, AND ALA-RÄMI A.
Role of cellular energetics in ischemia-reperfusion and ischemic
preconditioning of myocardium. Mol Cell Biochem 184: 393–400,
1998.
347. HATANO E, TANAKA A, IWATA S, SATOH S, KITAI T,
TSUNEKAWA S, INOMOTO T, SHINOHARA H, CHANCE B, AND
YAMAOKA Y. Induction of endotoxin tolerance in transgenic
mouse liver expressing creatine kinase. Hepatology 24: 663–669,
1996.
348. HATCH FT, COLVIN ME, AND SEIDL ET. Structural and quantum
chemical factors affecting mutagenic potency of aminoimidazoazaarenes.
Environ Mol Mutagen 27: 314–330, 1996.
349. HAUGLAND RB AND CHANG DT. Insulin effect on creatine transport
in skeletal muscle. Proc Soc Exp Biol Med 148: 1–4, 1975.
350. HAYASAKA S, SHIONO T, MIZUNO K, SAITO T, TADA K, MAT-
SUZAWA T, AND ISHIGURO I. Hyperornithinemia, gyrate atrophy,
and ornithine ketoacid transaminase. In: Urea Cycle Diseases,
edited by A. Lowenthal, A. Mori, and B. Marescau. New York:
Plenum, 1982, p. 353–358.
351. HAYASHI H, IIMURO M, MATSUMOTO Y, AND KANEKO M. Effects
of �-glutamylcysteine ethyl ester on heart mitochondrial
creatine kinase activity: involvement of sulfhydryl groups. Eur
J Pharmacol 349: 133–136, 1998.
352. HEGSTAD A-C, YTREHUS K, MYKLEBUST R, AND JØRGENSEN
L. Reversible ultrastructural alterations in the myocytic mitochondria
of isolated rat hearts induced by oxygen radicals. Ultrastruct
Pathol 21: 253–262, 1997.
353. HEMMER W, ZANOLLA E, FURTER-GRAVES EM, EPPEN-
BERGER HM, AND WALLIMANN T. Creatine kinase isoenzymes in
chicken cerebellum: specific localization of brain-type creatine
kinase in Bergmann glial cells and muscle-type creatine kinase in
Purkinje neurons. Eur J Neurosci 6: 538–549, 1994.
354. HENDERSON GD, XUE G-P, AND SNOSWELL AM. Carnitine and
creatine content of tissues of normal and alloxan-diabetic sheep
and rats. Comp Biochem Physiol B Biochem 76: 295–298, 1983.
355. HENSLEY K, CARNEY JM, MATTSON MP, AKSENOVA M, HAR-
RIS M, WU JF, FLOYD RA, AND BUTTERFIELD DA. A model for
�-amyloid aggregation and neurotoxicity based on free radical
generation by the peptide: relevance to Alzheimer’s disease. Proc
Natl Acad Sci USA 91: 3270–3274, 1994.
356. HERBST R, BARTON JL, AND NICKLIN MJH. A mammalian homolog
of the bacterial monomeric sarcosine oxidases maps to
mouse chromosome 11, close to Cryba1. Genomics 46: 480–482,
1997.
357. HERMANN M, KNERR H-J, MAI N, GROSS A, AND KALTWASSER